Chong Kun Dang Pharmaceutical: all 299 studies

Page 1 of 3. Open to participants first (15), then studies with results posted, then the rest; newest registration first within each.

• Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-339 in Healthy VolunteersNot yet recruitingNCT07748702Phase 1
• Study of CKD-215 and D215 in Adults With BRCA-mutated Advanced Ovarian, Fallopian Tube, or Primary Peritoneal CancerNot yet recruitingNCT07532148Phase 1
• A First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lung CancerRecruitingNCT07439094Phase 1/2
• Evaluate the Efficacy and Safety of Empagliflozin or Glimepiride Combination Therapy in Type 2 Diabetes Mellitus PatientsNot yet recruitingNCT07365358Phase 4
• A Study to Compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of CKD-706 With US-Dupixent®, and EU-Dupixent® in Healthy Adult Participants.RecruitingNCT07358156Phase 1
• Pharmacokinetic, Safety, Tolerability, and Immunogenicity Comparison of CKD-704 (Risankizumab Biosimilar), With EU-approved Skyrizi®, and US-licensed Skyrizi® in Healthy Adult ParticipantsRecruitingNCT07258745Phase 1
• Phase Ia/Ib Study of CKD-512 Alone and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Solid TumorsRecruitingNCT07215637Phase 1
• Optimize Immunosuppressive Therapy Using Everolimus and Low-dose Calcineurin Inhibitors in Heart Transplant Patients in KoreaNot yet recruitingNCT06942156Phase 4
• A Phase 3 Study to Evaluate the Safety and Efficacy of CKD-843 in Male Patients With Androgenetic AlopeciaRecruitingNCT06916793Phase 3
• Korean Study on Safety and Effectiveness of OAD Triple Therapy in Type 2 DiabetesRecruitingNCT06838286
• Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202ARecruitingNCT06643819Phase 3
• To Evaluate the Food Effect on Pharmacokinetic Profiles and Safety in Healthy VolunteersNot yet recruitingNCT06492655Phase 1
• Efficacy and Safety of Telmisartan Compared With LosartanRecruitingNCT06431477Phase 4
• Efficacy and Safety of EsoDuo®RecruitingNCT06430047Phase 4
• A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic SyndromeNot yet recruitingNCT05843162Phase 4
• Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy VolunteersCompletedNCT02631954Phase 1Results posted
• A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846CompletedNCT07404735Phase 1
• Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.25/12.5/1000mg in Healthy VolunteersCompletedNCT07304726Phase 1
• Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.5/10/1000mg in Healthy VolunteersCompletedNCT07304700Phase 1
• Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.5/25/1000mg in Healthy VolunteersCompletedNCT07304687Phase 1
• A Drug-drug Interaction Study to Investigate the Pharmacokinetic Interactions Between CKD-508, Midazolam, and Rosuvastatin in Healthy Adult Male ParticipantsCompletedNCT06979973Phase 1
• Retrospective Observational Study on GERD Management in General Hospitals in KoreaCompletedNCT06974903
• Initial Pilot Study to Evaluate the Safety and Temporary Symptom Improvement Efficacy of CKD-981CompletedNCT06954766Phase 2
• Clinical Study to Evaluate Drug-drug Interaction and Safety After Co-administration of D352 and D794 in Healthy Adult VolunteersCompletedNCT06758661Phase 1
• A Study to Investigate the Safety, Tolerability, PK, and PD of CKD-508 in Healthy ParticipantsCompletedNCT06727396Phase 1
• Clinical Study to Evaluate the Food Effect of CKD-378 in Healthy VolunteersCompletedNCT06709807Phase 1
• Clinical Study to Evaluate the Food Effect of CKD-383 0.5/25/1000mg in Healthy VolunteersCompletedNCT06695598Phase 1
• Clinical Study to Evaluate the Food Effect of CKD-383 0.5/10/1000mg in Healthy VolunteersCompletedNCT06695572Phase 1
• A Clinical Trial to Evaluate the Food Effect of CKD-379CompletedNCT06652971Phase 1
• Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic of CKD-501, D745, and D150 for Healthy Subjects in Fed State.CompletedNCT06483243Phase 1
• Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fed ConditionsCompletedNCT06399068Phase 1
• Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fasting ConditionsCompletedNCT06399055Phase 1
• A Clinical Trial to Evaluate the Food Effect of CKD-378CompletedNCT06386328Phase 1
• Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D956 in Healthy AdultsCompletedNCT06281132Phase 1
• A Clinical Trial to Evaluate the Food Effect on Pharmacokinetic Profiles and Safety of CKD-379CompletedNCT06204107Phase 1
• Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Versus D064 or D702 MonotherapyCompletedNCT06121518Phase 3
• A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(6)CompletedNCT06112678Phase 1
• A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846CompletedNCT06110923Phase 1
• A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391(2)CompletedNCT06088017Phase 1
• MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant RecipientsCompletedNCT06044493Phase 4
• Study to Evaluate the Safety and Pharmacokinetics of CKD-379Active, not recruitingNCT05952219Phase 1
• Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination TherapyCompletedNCT05931224Phase 3
• A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of D745, D759, and D150CompletedNCT05928637Phase 1
• Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D958 in Healthy AdultsCompletedNCT05921435Phase 1
• Evaluate the Pharmacokinetics and Safety Between the Treatment of CKD-383 and Treatment of CKD-501, D745, D150, and D029CompletedNCT05897216Phase 1
• A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828 20/1.25mgCompletedNCT05881707Phase 1
• Clinical Trial to Investigate the Pharmacokinetics and Safety After Oral Administration of CKD-378 and Co-administration of D745, D150, D029 in Healthy AdultsCompletedNCT05881213Phase 1
• A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828CompletedNCT05834595Phase 1
• Evaluate the Pharmacokinetics and Safety Between the Administration of CKD-383 and the Co-administration of CKD-501, D744, and D150CompletedNCT05816759Phase 1
• A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(5)CompletedNCT05749861Phase 1
• A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-378CompletedNCT05741437Phase 1
• Pharmacokinetics and Safety/Tolerability of CKD-379CompletedNCT05719155Phase 1
• A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(5) 80/20/10mgCompletedNCT05698043Phase 1
• A Phase 2 Study to Evaluate the Safety and Efficacy of CKD-498 in Female Patients With Androgenetic AlopeciaCompletedNCT05677438Phase 2
• Clinical Study to Evaluate Pharmacokinetic Profiles and Safety of CKD-387 Under Fasting ConditionCompletedNCT05673369Phase 1
• A Clinical Trial to Evaluate the Efficacy and Safety of CKD-391 and CKD-331 in Patients With Primary HypercholesterolemiaStatus unknownNCT05657574Phase 3
• A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391CompletedNCT05634447Phase 1
• The Parallel Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of CKD-843 ACompletedNCT05587699Phase 1
• Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-341 in Healthy SubjectsCompletedNCT05571813Phase 1
• The Efficacy and Safety of D745 Added to D150 Plus D759 Therapy in Patients with Type 2 DiabetesCompletedNCT05566028Phase 3
• Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-386 in Healthy Volunteers Under Fasting ConditionsCompletedNCT05552495Phase 1
• Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348CompletedNCT05549401Phase 1
• Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD 371 in Healthy SubjectsCompletedNCT05544214Phase 1
• Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-828 in Healthy SubjectsCompletedNCT05540912Phase 1
• A Study to Evaluate the Relative Bioavailability of Formulations of CKD-510 and to Assess the Effect of Food on the CKD-510 Tablet Formulation in Healthy SubjectsCompletedNCT05526742Phase 1
• Clinical Trial to Evaluate the Efficacy and Safety of D064 and D701 Combination TherapyStatus unknownNCT05526703Phase 3
• Pharmacokinetics and Safety/Tolerability Profile of CKD-379CompletedNCT05452525Phase 1
• A Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393(2) in Healthy Volunteers Under Fed ConditionsCompletedNCT05347576Phase 1
• Study to Evaluate the Safety and Pharmacokinetics of CKD-331CompletedNCT05335044Phase 1
• Study to Evaluate the Food Effect on Pharmacokinetics Profile and Safety of CKD-393CompletedNCT05274880Phase 1
• A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(3) 80/20/10mgCompletedNCT05245084Phase 1
• CKD-506 Drug-Drug Interaction Study in Healthy Male SubjectsCompletedNCT05238948Phase 1
• Study to Evaluate Drug-drug Interaction, Safety and Tolerability in Case of the Co-administration of D565 and D930CompletedNCT05207761Phase 1
• Study to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in Kidney Transplant PatientsActive, not recruitingNCT05193565Phase 4
• A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(3)CompletedNCT05192356Phase 1
• Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388(2) in Healthy SubjectsCompletedNCT05189288Phase 1
• Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393CompletedNCT05113693Phase 1
• A Study to Evaluate the PK, PD and Safety of CKD-382 in Healthy SubjectsStatus unknownNCT05108038Phase 1
• Study to Evaluate the Safety and Pharmacokinetics of CKD-349 in Healthy Adult VolunteersCompletedNCT05089279Phase 1
• A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate in Vascular Cognitive Impairment PatientsStatus unknownNCT05050604Phase 4
• Retrospective Study to Evaluate the Safety of Duvie in Korean Patients With Type 2 Diabetes MellitusCompletedNCT05043467
• A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive ImpairmentStatus unknownNCT05041790Phase 4
• A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) 80/20/10mgCompletedNCT04987970Phase 1
• Clinical Study to Compare the Pharmacokinetics and Safety of D113 With CKD-349 in Healthy VolunteersCompletedNCT04952506Phase 1
• Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting ConditionsStatus unknownNCT04906798Phase 1
• Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed ConditionsStatus unknownNCT04906785Phase 1
• A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(2)CompletedNCT04883658Phase 1
• Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of CKD-314Status unknownNCT04871646Phase 3
• Evaluate the Drug-drugs Interaction Between Lobeglitazone 0.5mg and Empagliflozin 25mgCompletedNCT04869800Phase 1
• Efficacy and Safety of CertiroBell® Tablet Plus Tacrolimus in Primary Living Donor Liver Transplant RecipientsStatus unknownNCT04867720Phase 4
• A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344 in Healthy VolunteersStatus unknownNCT04867200Phase 1
• A Study To Evaluate CKD-701 and Lucentis® in Patients With Neovascular(Wet) Age Related Macular DegenerationCompletedNCT04857177Phase 3
• The Safety and Pharmacokinetic/Pharmacodynamic Study of CKD-841 in Postmenopausal Female, Phase 1Status unknownNCT04840745Phase 1
• A Study to Investigate the Effect of Food on the PK, PD of CKD-381 in Healthy VolunteersCompletedNCT04830930Phase 1
• A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-383.CompletedNCT04810676Phase 1
• A Clinical Traial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of CKD-843CompletedNCT04805606Phase 1
• A Study to Investigate the PK and Safety of CKD-393CompletedNCT04768673Phase 1
• Evaluation of the Safety and Tolerability of CKD-510 in Healthy SubjectsCompletedNCT04746287Phase 1
• Clinical Trial to Investigate the Pharmacokinetics and Safety of CKD-393Status unknownNCT04706286Phase 1
• A Study to Compare PK, PD and Safety of CKD-382 in Healthy SubjectsStatus unknownNCT04703374Phase 1

← Chong Kun Dang Pharmaceutical overview and focus areas